Cargando…
Efficacy and Safety of Antiplatelet Therapy Plus Xa Factor Inhibitors in Patients with Coronary Heart Disease: A Meta-Analysis
BACKGROUND: The aim of this study was to systematically evaluate the effect of oral Xa inhibitors plus antiplatelet therapy in the treatment of coronary artery disease. MATERIAL/METHODS: All randomized controlled trials (RCTs) about antiplatelet therapy plus Xa factor inhibitors for coronary artery...
Autores principales: | Chen, Hongsen, Chen, Chensong, Fang, Junjie, Wang, Ren, Nie, Wanshui, Yuan, Qionghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668492/ https://www.ncbi.nlm.nih.gov/pubmed/31335859 http://dx.doi.org/10.12659/MSM.917774 |
Ejemplares similares
-
Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta‐analysis
por: Wongsalap, Yuttana, et al.
Publicado: (2023) -
Comparative analysis and meta-analysis of major clinical trials with oral factor Xa inhibitors versus warfarin in atrial fibrillation
por: Nunes, José Pedro L, et al.
Publicado: (2014) -
Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis
por: Yu, Hai-Han, et al.
Publicado: (2017) -
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma
por: Lai, Quirino, et al.
Publicado: (2022) -
Efficacy and safety of short-term (≤6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
por: Xiang, Chun-Lin, et al.
Publicado: (2017)